These compounds may interact with:
Mu-type opioid receptor
Potentially involved in: alcohol dependence; opiate dependence; cardiovascular system disease; carcinoma; pain agnosia; withdrawal disorder; nicotine dependence; mucopolysaccharidosis iv; constipation; substance abuse; cancer; salmonellosis; histrionic personality disorder; tetanus neonatorum; alcoholic intoxication; alcoholic intoxication, chronic; mental depression; depressive disorder; dyskinetic syndrome; epilepsy
Disease data sourced from Pharos.